HomeSPRB • OTCMKTS
Spruce Biosciences Inc
add
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 3.66M | -15.35% |
Net income | -14.04M | -20.78% |
Net profit margin | — | — |
Earnings per share | -0.32 | -14.29% |
EBITDA | -14.49M | -14.80% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Cash and short-term investments | 25.62M | -68.44% |
Total assets | 31.65M | -63.85% |
Total liabilities | 16.33M | -21.95% |
Total equity | 15.32M | — |
Shares outstanding | 42.23M | — |
Price to book | 0.17 | — |
Return on assets | -94.28% | — |
Return on capital | -147.26% | — |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Mar 2025info | Y/Y change |
---|---|---|
Net income | -14.04M | -20.78% |
Cash from operations | -12.73M | 14.92% |
Cash from investing | — | — |
Cash from financing | -411.00K | -81.06% |
Net change in cash | -13.14M | 13.48% |
Free cash flow | -7.35M | 35.11% |
Previous close
$0.062
Day range
$0.058 - $0.067
Year range
$0.057 - $0.090
Market cap
2.88M USD
Avg Volume
862.53K
P/E ratio
-
Dividend yield
-
Primary exchange
OTCMKTS
About
Founded
2014
Headquarters
Website
Employees
20